The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury

Journal of Neurotrauma

Volumn 29, Issue 5, 2012, Pages 851-864

  Zhang, Lili ^a   Liu, Jie ^a   Cheng, Chun ^a   Yuan, Ying ^a   Yu, Biyun ^a   Shen, Aiguo ^a   Yan, Meijuan ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

1,4 galactosyltransferase I; 4 galactosyltransferase Nacylsphingosine group; 4 galactosyltransferase V; galactosidase 1; Morris water maze; pyrroloquinoline quinone; training; traumatic brain injury

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE 1; BETA 1,4 GALACTOSYLTRANSFERASE 5; BETA N ACETYLGLUCOSAMINYLGLYCOPEPTIDE BETA 1,4 GALACTOSYLTRANSFERASE; CENTRAL NERVOUS SYSTEM AGENTS; N ACYLSPHINGOSINE GALACTOSYLTRANSFERASE; PYRROLOQUINOLINEQUINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; DRUG EFFECT; LEARNING; MALE; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN INJURIES; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSYLTRANSFERASES; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PQQ COFACTOR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863369662     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1882     Document Type: Article

References (37)

1. Aizenman, E., Hartnett, K.A., Zhong, C., Gallop, P.M., and Rosenberg, P.A. (1992). Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J. Neurosci. 12, 2362-2369.
2. Alexandrova, M.L., and Bochev, P.G. (2005). Oxidative stress during the chronic phase after stroke. Free Radic. Biol. Med. 39, 297-316. (Pubitemid 40910187)
3. Allendoerfer, K.L., Durairaj, A., Matthews, G.A., and Patterson, P.H. (1999). Morphological domains of Lewis-X/FORSE-1 immunolabeling in the embryonic neural tube are due to developmental regulation of cell surface carbohydrate expression. Dev. Biol. 211, 208-219. (Pubitemid 29343277)
4. Asano, M., Nakae, S., Kotani, N., Shirafuji, N., Nambu, A., Hashimoto, N., Kawashima, H., Hirose, M., Miyasaka, M., Ta-kasaki, S., and Iwakura, Y. (2003). Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4-galactosyltransferase-I-deficient mice. Blood 102, 1678-1685. (Pubitemid 37022560)
5. Dixon, C.E., Clifton, G.L., Lighthall, J.W., Yaghmai, A.A., and Hayes, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262.
6. Furukawa, K., and Sato, T. (1999). Beta-1,4-galactosylation of N-glycans is a complex process. Biochim. Biophys. Acta. 1473, 54-66.
7. Gallop, P.M., Henson, E., Paz, M.A., Greenspan, S.L., and Fluckiger, R. (1989a). Acid-promoted tautomeric lactonization and oxidation-reduction of pyrroloquinoline quinone (PQQ). Biochem. Biophys. Res. Commun. 163, 755-763. (Pubitemid 19236915)
8. Gallop, P.M., Paz, M.A., Fluckiger, R., and Henson, E. (1993). Is the antioxidant, anti-inflammatory putative new vitamin, PQQ, involved with nitric oxide in bone metabolism? Connect. Tissue Res. 29, 153-161.
9. Gallop, P.M., Paz, M.A., Fluckiger, R., and Kagan, H.M. (1989b). PQQ, the elusive coenzyme. Trends Biochem. Sci. 14, 343-346. (Pubitemid 19190544)
10. Hamagishi, Y., Murata, S., Kamei, H., Oki, T., Adachi, O., and Ameyama, M. (1990). New biological properties of pyrrolo-quinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J. Pharmacol. Exp. Ther. 255, 980-985.
11. He, K., Nukada, H., Urakami, T., and Murphy, M.P. (2003). Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 65, 67-74. (Pubitemid 35447840)
12. Kasahara, T., and Kato, T. (2003). Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature 422, 832. (Pubitemid 36520027)
13. Killgore, J., Smidt, C., Duich, L., Romero-Chapman, N., Tinker, D., Reiser, K., Melko, M., Hyde, D., and Rucker, R.B. (1989). Nutritional importance of pyrroloquinoline quinone. Science 245, 850-852. (Pubitemid 19223660)
14. Kim, J., Harada, R., Kobayashi, M., Kobayashi, N., and Sode, K. (2010).The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synu-clein. Mol. Neurodegener. 5, 20.
15. Kobayashi, M., Kim, J., Kobayashi, N., Han, S., Nakamura, C., Ikebukuro, K., and Sode, K. (2006). Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem. Biophys. Res. Commun. 349, 1139-1144. (Pubitemid 44380214)
16. Kumazawa, T., Seno, H., Urakami, T., Matsumoto, T., and Suzuki, O. (1992). Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim. Biophys. Acta. 1156, 62-66. (Pubitemid 23004906)
17. Kumazawa, T., Sato, K., Seno, H., Ishii, A., and Suzuki, O. (1995). Levels of pyrroloquinoline quinone in various foods. Biochem. J. 307(Pt. 2), 331-333.
18. Liedtke, S., Geyer, H., Wuhrer, M., Geyer, R., Frank, G., Gerardy-Schahn, R., Zahringer, U., and Schachner, M. (2001). Characterization of N-glycans from mouse brain neural cell adhesion molecule. Glycobiology 11, 373-384. (Pubitemid 32685212)
19. Mori, R., Kondo, T., Nishie, T., Ohshima, T., and Asano, M. (2004). Impairment of skin wound healing in beta-1,4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. Am. J. Pathol. 164, 1303-1314. (Pubitemid 38387796)
20. Nakamura, N., Yamakawa, N., Sato, T., Tojo, H., Tachi, C., and Furukawa, K. (2001). Differential gene expression of beta-1,4-galactosyltransferases I, II and V during mouse brain development. J. Neurochem. 76, 29-38. (Pubitemid 32044365)
21. Niu, S., Fei, M., Cheng, C., Yan, M., Gao, S., Chen, M., Wang, H., Li, X., Yu, X., Qian, J., Qin, J., Zhao, J., Gu, J., and Shen, A. (2008). Altered beta-1,4-galactosyltransferase I expression during early inflammation after spinal cord contusion injury. J. Chem. Neuroanat. 35, 245-256.
22. Nunome, K., Miyazaki, S., Nakano, M., Iguchi-Ariga, S., and Ariga, H. (2008). Pyrroloquinoline quinone prevents oxida-tive stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol. Pharm. Bull. 31, 1321-1326. (Pubitemid 351930640)
23. Ohwada, K., Takeda, H., Yamazaki, M., Isogai, H., Nakano, M., Shimomura, M., Fukui, K., and Urano, S. (2008). Pyrroloqui-noline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J. Clin. Biochem. Nutr. 42, 29-34. (Pubitemid 351252893)
24. Paz, M.A., Fluckiger, R., Torrelio, B.M., and Gallop, P.M. (1989). Methoxatin (PQQ), coenzyme for copper-dependent amine and mixed-function oxidation in mammalian tissues. Connect. Tissue Res. 20, 251-257.
25. Ronn, L.C., Berezin, V., and Bock, E. (2000). The neural cell adhesion molecule in synaptic plasticity and ageing. Int. J. Dev. Neurosci. 18, 193-199. (Pubitemid 30129193)
26. Salisbury, S.A., Forrest, H.S., Cruse, W.B., and Kennard, O. (1979). A novel coenzyme from bacterial primary alcohol de-hydrogenases. Nature 280, 843-844. (Pubitemid 9254046)
27. Sanchez, R.M., Wang, C., Gardner, G., Orlando, L., Tauck, D.L., Rosenberg, P.A., Aizenman, E., and Jensen, F.E. (2000). Novel role for the NMDA receptor redox modulatory site in the patho-physiology of seizures. J. Neurosci. 20, 2409-2417. (Pubitemid 30230093)
28. Scanlon, J.M., Aizenman, E., and Reynolds, I.J. (1997). Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur. J. Pharmacol. 326, 67-74. (Pubitemid 27205047)
29. Shen A., Wang H., Zhang Y., Yan J., Zhu D., and Gu J. (2002). Expression of beta-1,4-galactosyltransferase II and V in rat injured sciatic nerves. Neurosci. Lett. 327, 45-48. (Pubitemid 34727352)
30. Tsuchida, T., Yasuyama, T., Higuchi, K., Watanabe, A., Ur-akami, T., Akaike, T., Sato, K., and Maeda, H. (1993). The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride- induced liver injury of rats. J. Gastroenterol. Hepatol. 8, 342-347. (Pubitemid 23203400)
31. Venkatesh Y.P., and J.M. Lambert. (1997). Galactose-induced dimerization of blocked ricin at acidic pH: evidence for a third galactose-binding site in ricin b-chain. Glycobiology 7, 329-335. (Pubitemid 27187438)
32. Vorhees, C.V., and Williams, M.T. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848-858.
33. Yan, M., Cheng, C., Shao, X., Qian, J., Shen, A., and Xia, C. (2008). Expression change of beta-1,4 galactosyltransferase I, V mRNAs and Galbeta1,4GlcNAc group in rat sciatic nerve after crush. J. Mol. Histol. 39, 317-328.
34. Zhang, J.J., Zhang, R.F., and Meng, X.K. (2009). Protective effect of pyrroloquinoline quinone against Abeta-induced neuro-toxicity in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 464, 165-169.
35. Zhang, Y., Feustel, P.J., and Kimelberg, H.K. (2006). Neuroprotec-tion by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. 1094, 200-206. (Pubitemid 43927615)
36. Zhou D., Chen C., Jiang S., Shen Z., Chi Z., and Gu J. (1998). Expression of b1,4-galactosyltransferase in the development of mouse brain. Biochim. Biophys. Acta 1425, 204-208. (Pubitemid 28479726)
37. Zhu, B.Q., Zhou, H.Z., Teerlink, J.R., and Karliner, J.S. (2004). Pyr-roloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and is-chemia/reperfusion. Cardiovasc. Drugs Ther. 18, 421-431. (Pubitemid 40487020)